Skip to Content Facebook Feature Image

Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel's "Poetics of Time" Brand Positioning

Business

Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel's "Poetics of Time" Brand Positioning
Business

Business

Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel's "Poetics of Time" Brand Positioning

2026-01-26 22:48 Last Updated At:23:05

SHANGHAI, Jan. 26, 2026 /PRNewswire/ -- Moyom Biotechnology today announced a strategic partnership with WPP Group, a leading creative transformation company that provides integrated brand, media, public relations, data, and technology solutions worldwide.

Headquartered in London, WPP Group operates in more than 100 countries worldwide, integrating capabilities across creative, media, public relations, digital, consulting, and artificial intelligence. Through the partnership, WPP will draw on its global resources and integrated expertise to help Aphranel establish a clear, consistent, and internationally relevant, market-ready brand narrative, while communicating the values and the underlying scientific and clinical approach behind Poetics of Time to a broader professional audience.

Aphranel is a core brand of Moyom Biotechnology, positioned as the first CaHA-based regenerative injectable to receive regulatory approval in China. The brand is defined by an approach centered on a return to core medical principles, emphasizing structural support and long-term biological processes aligned with the natural rhythm of time.

"Poetics of Time" reflects Aphranel's belief that aesthetic medicine should move beyond the notion of resisting aging, and instead focus on respecting anatomy, material science, and long-term clinical value. The partnership with WPP represents a key step in strengthening the brand's global expression at the intersection of regenerative science and a clinically grounded, time-based medical philosophy.

Moyom Biotechnology said that it will continue working with WPP to expand the international reach of Aphranel and further build long-term brand trust and consistency across global markets.

About Aphranel

Aphranel is a core brand of Moyom Biotechnology, focused on professional medical aesthetics applications for clinical use. The brand specializes in facial injectables and regenerative materials, driven by science-based development and a sustained commitment to long-term clinical value.

About Moyom Biotechnology

Moyom Biotechnology is a medical technology company dedicated to regenerative materials and professional medical aesthetics, with a focus on science-based solutions and sustainable innovation in healthcare delivery.

About WPP

WPP is the creative transformation company. We use the power of creativity to build better futures for our people, planet, clients and communities. For more information, visit wpp.com.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel's "Poetics of Time" Brand Positioning

Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel's "Poetics of Time" Brand Positioning

NEW YORK, Jan. 26, 2026 /PRNewswire/ --  Five Sigma, the AI claims technology company, today announced that Starr, a global investment and insurance organization, has selected Five Sigma's AI-native Claims Management Platform and Clive™, the Multi-Agent AI Claims Expert, to support the next phase of its digital claims transformation.

"The future of claims isn't about digitizing legacy processes, it's about reimagining what's possible when you build on true AI-native infrastructure from the ground up," said Oded Barak, Co-founder and CEO of Five Sigma. "Starr is a market leader that underwrites complexity at scale. Their decision to partner with Five Sigma reflects a strategic commitment to modernizing claims operations and advancing the standard for the industry."

David Fitzgerald, Global Chief Claims Officer at Starr said, "We chose Five Sigma because they truly understand the complexity of global commercial and specialty claims. We're giving our adjusters the best tools available, creating a single source of truth, and delivering the kind of claims experience that keeps policyholders with us for decades."

Five Sigma's AI Claims Management Platform, together with Clive™, the insurance industry's first multi-agent AI Claims Expert, embeds intelligence directly into every stage of the claims lifecycle. The platform continuously analyzes data, orchestrates workflows, and guides adjusters in real time - enabling faster, more accurate decisions from first notice of loss (FNOL) through resolution. With Five Sigma, Starr can drive material reductions in cycle times, lower loss adjustment expense, and significantly increase adjuster productivity across its claims operations.

"Starr's transformation is a blueprint for what every commercial and specialty insurer should be thinking about right now," said Barak. "The carriers that move decisively to AI infrastructure today will be best positioned to lead their markets tomorrow."

About Five Sigma

Five Sigma provides AI-native claims management technology to insurers, MGAs, TPAs, and reinsurers. Clive™, Five Sigma's award-winning Multi-Agent AI Claims Expert, acts as an AI adjuster that works on any existing claims management system. Clive automates routine tasks, dynamically plans claim handling, and advances claims according to each insurer's operating procedures, adding intelligence and automation to any platform. Five Sigma's customers report measurable improvements in claims operations: cost savings, productivity gains, faster cycle time, and superior policyholder service. To learn more about how Five Sigma is transforming claims, visit fivesigmalabs.com.

About Starr

Starr is a leading global investment and insurance organization with a presence on six continents. Through its operating insurance companies, Starr provides property, casualty, and accident and health insurance products, as well as a range of specialty coverages, including aviation, marine, energy, and excess casualty insurance. Starr's insurance company subsidiaries domiciled in the U.S., Bermuda, China, Hong Kong, Malta, Singapore, Switzerland, and the U.K. each have an A.M. Best rating of "A" (Excellent). Starr's Lloyd's syndicate has a Standard & Poor's rating of "A+" (Strong). Starr is the marketing name for the investment business of C. V. Starr & Co., Inc. and the insurance and travel assistance companies of Starr International Company, Inc., and their subsidiaries. Click here to learn more: https://starr.com/

Contact:
Tirtza Bensoussan | info@fivesigmalabs.com

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Starr Modernizes P&C and Specialty Claims with Five Sigma's AI Claims Platform and Clive™

Starr Modernizes P&C and Specialty Claims with Five Sigma's AI Claims Platform and Clive™

Recommended Articles